GUR ROSHWALB, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Viracta Therapeutics, Inc.

Filing Date Source Excerpt
2022-04-27 Dr. Roshwalb will be departing from the board of directors following the Annual Meeting and Viracta thanks him for his service as a director. Director Compensation table shows total compensation of $552,847.

Data sourced from SEC filings. Last updated: 2026-03-09